InfuSystem Holdings, Inc

INFU

InfuSystem Holdings, Inc

INFU

Insider Sentiment (TTM):

Last Purchase:2026-05-11Last Sale:2025-08-22Shares Purchased (TTM):15,064Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:13,290,995Shares Outstanding:20,211,045Institutional Ownership Pct.:65.76%

Earnings Market Reaction:

Filing Date:2026-08-04Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	1	2	3	1	1	2	1	0	0	1	0	0
Accounts Receivable Net Current	27	24	23	24	24	24	21	23	21	21	20	19
Inventory Net	6	6	5	6	6	6	7	7	7	6	6	6
Other Assets Current	5	5	5	5	4	4	4	4	5	5	4	4
Assets Current	38	37	36	36	35	35	32	34	33	32	31	30
Property Plant And Equipment Net	3	3	3	4	4	4	4	4	4	4	4	4
Goodwill	4	4	4	4	4	4	4	4	4	4	4	4
Intangible Assets Net Excluding Goodwill	6	7	7	7	7	6	6	7	7	7	7	8
Operating Lease Right Of Use Asset	4	4	4	5	5	5	5	6	6	6	7	4
Deferred Income Tax Assets Net	4	4	5	5	6	7	7	8	9	9	9	9
Derivative Assets Noncurrent	1	1	1	1	1	1	1	1	2	2	1	2
Other Assets Noncurrent	2	2	2	0	0	1	1	1	1	2	2	2
Assets	98	99	101	99	101	104	104	105	109	105	103	102
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	9	10	11	10	9	8	10	9	10	10	8	8
Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	-	0
Other Liabilities Current	6	8	9	9	7	8	8	8	6	8	8	7
Liabilities Current	15	17	20	19	16	16	18	17	16	17	16	14
Long Term Debt Noncurrent	20	20	20	21	26	29	24	28	34	30	29	33
Operating Lease Liability Noncurrent	3	3	3	4	4	4	5	5	5	5	6	4
Liabilities	39	40	43	43	46	49	46	50	55	53	51	51
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	119	119	117	116	115	115	114	113	111	111	110	109
Accumulated Other Comprehensive Income Loss Net Of…	1	1	1	1	1	1	1	1	1	1	1	2
Retained Earnings Accumulated Deficit	-61	-61	-61	-61	-62	-61	-57	-58	-59	-60	-59	-59
Stockholders Equity	59	59	57	55	55	55	58	56	53	52	52	51
Liabilities And Stockholders Equity	98	99	101	99	101	104	104	105	109	105	103	102
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	1	1	1	1	1	1	1	1	1	1	1	1
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	20	20	20	20	20	21	21	21	21	21	21	21
Shares Outstanding	20	20	20	20	20	21	21	21	21	21	21	21

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	7.85%	19.50%	8.44%	-	-	-	-	-	-	-	-	-
2025	5.67%	11.88%	9.87%	77.59%	70.35%	66.89%	-1.90%	-5.29%	-10.36%	3.65%	20.64%	0.00%
2024	-5.56%	-9.66%	-8.73%	10.83%	12.50%	8.83%	13.96%	4.23%	3.97%	-11.85%	-12.93%	3.77%
2023	-	-	-	-8.63%	-14.23%	-12.63%	17.44%	22.56%	11.98%	-6.82%	-11.52%	-15.37%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	2.50	2.14	1.80	1.90	2.19	2.21	1.82	1.98	2.07	1.87	1.95	2.08
Quick Ratio	2.14	1.80	1.53	1.60	1.84	1.83	1.45	1.59	1.64	1.51	1.54	1.66
Working Capital	22.97M	19.52M	16.15M	16.85M	18.94M	19.35M	14.50M	16.68M	17.03M	15.14M	14.91M	15.44M
Leverage & Debt
Debt to Equity	0.65	0.68	0.75	0.78	0.85	0.89	0.80	0.90	1.03	1.01	0.97	0.98
Interest Coverage TTM	11.18	10.58	9.18	6.69	5.70	5.04	3.88	2.61	1.89	1.56	1.88	1.83
Debt Ratio	0.39	0.40	0.43	0.44	0.46	0.47	0.44	0.47	0.51	0.50	0.49	0.50
Efficiency & Turnover
Asset Turnover TTM	1.45	1.40	1.41	1.35	1.31	1.32	1.31	1.26	1.21	1.23	1.24	1.19
Days Sales Outstanding TTM	65.34	61.35	56.05	62.10	60.95	58.94	55.46	58.74	57.42	55.59	53.25	54.44
Receivables Turnover TTM	5.59	5.95	6.51	5.88	5.99	6.19	6.58	6.21	6.36	6.57	6.85	6.70
Per Share Metrics
Diluted EPS TTM	0.35	0.38	0.31	0.22	0.20	0.15	0.11	0.10	0.05	0.00	0.04	0.04
Free Cash Flow Per Share TTM	1.14	1.14	1.15	1.19	1.23	0.99	0.91	0.76	0.50	0.51	0.49	0.48
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	56.69%	56.75%	55.98%	54.49%	53.66%	53.13%	52.20%	51.37%	50.06%	50.73%	50.17%	51.06%
Operating Profit Margin TTM	8.52%	9.05%	8.31%	6.77%	6.43%	6.07%	5.11%	4.78%	3.68%	2.63%	3.25%	2.89%
Net Profit Margin TTM	5.03%	5.56%	4.62%	3.38%	3.08%	2.32%	1.74%	1.73%	0.90%	0.07%	0.69%	0.72%
Growth Metrics
Net Revenue Growth (1Y)	5.25%	3.50%	6.36%	5.47%	7.37%	7.98%	7.22%	10.00%	11.47%	12.23%	14.44%	13.23%
Net Income Growth (1Y)	71.73%	147.99%	182.60%	105.94%	266.29%	3,697.62%	168.92%	163.27%	87.03%	35.48%	4,744.44%	-34.97%
EPS Growth (1Y)	78.03%	159.21%	191.00%	114.79%	274.95%	3,715.73%	165.80%	160.86%	84.01%	33.10%	4,657.91%	-36.24%
Valuation Metrics
P/E TTM	26.68	23.58	27.96	45.20	30.72	35.63	76.65	62.78	126.06	2,165.53	254.12	235.64
P/B TTM	3.27	3.18	3.23	3.81	2.38	2.06	3.12	2.57	2.72	3.48	4.24	3.95
P/S TTM	1.34	1.31	1.29	1.53	0.95	0.83	1.33	1.09	1.14	1.43	1.76	1.71
Market Cap	193.69M	186.55M	185.30M	211.49M	129.84M	113.65M	179.75M	142.65M	145.47M	181.90M	221.60M	203.36M
Enterprise Value	213.15M	204.09M	204.92M	231.46M	155.46M	140.85M	203.08M	170.24M	179.49M	211.01M	250.47M	235.85M
Calculated Values
Free Cash Flow TTM	22.91M	23.01M	23.85M	24.26M	25.64M	20.82M	19.37M	16.22M	10.56M	10.86M	10.20M	10.10M
Net Debt	19.46M	17.54M	19.62M	19.98M	25.63M	27.20M	23.34M	27.60M	34.02M	29.11M	28.87M	32.49M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-05-11Purchase

Owner: Lachance, Carrie

Title: President and CEO

Shares: 1,000

Price/Share: $8.46

Value: $8,460.00

Shares Owned: 238,123

Relationship: Director,Officer

Ownership: Direct

2026-05-08Purchase

Owner: Steele, Barry G

Title: Executive VP and CFO

Shares: 7,000

Price/Share: $8.71

Value: $60,970.00

Shares Owned: 96,590

Relationship: Officer

Ownership: Direct

2026-05-08Purchase

Owner: Gendron, Paul Andrew

Title: -

Shares: 5,000

Price/Share: $8.88

Value: $44,400.00

Shares Owned: 70,000

Relationship: Director

Ownership: Direct

2026-03-02Purchase

Owner: Steele, Barry G

Title: Executive VP and CFO

Shares: 2,064

Price/Share: $9.16

Value: $18,906.24

Shares Owned: 88,000

Relationship: Officer

Ownership: Direct

2025-08-22Sale

Owner: Shuda, Scott

Title: -

Shares: 5,752

Price/Share: $9.67

Value: $55,621.84

Shares Owned: 94,000

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-05-11	Lachance, Carrie	Director,Officer	President and CEO	Direct	Purchase	1,000	8.46	$8,460.00	238,123	4
2026-05-08	Steele, Barry G	Officer	Executive VP and CFO	Direct	Purchase	7,000	8.71	$60,970.00	96,590	4
2026-05-08	Gendron, Paul Andrew	Director	-	Direct	Purchase	5,000	8.88	$44,400.00	70,000	4
2026-03-02	Steele, Barry G	Officer	Executive VP and CFO	Direct	Purchase	2,064	9.16	$18,906.24	88,000	4
2025-08-22	Shuda, Scott	Director	-	Direct	Sale	5,752	9.67	$55,621.84	94,000	4
2025-05-28	Eichenbaum, Kenneth D.	Director	-	Direct	Purchase	2,000	5.18	$10,360.00	6,000	4
2025-05-19	Hundzinski, Ronald T	Director	-	Direct	Purchase	5,000	6.09	$30,450.00	5,000	4
2025-05-16	Lachance, Carrie	Director,Officer	President and COO	Direct	Purchase	1,967	6.10	$11,998.70	190,212	4
2025-05-14	Steele, Barry G	Officer	Executive VP and CFO	Direct	Purchase	3,000	5.76	$17,280.00	76,887	4
2024-11-27	Dilorio, Richard	Director,Officer	Chief Executive Officer	Direct	Sale	5,398	8.87	$47,880.26	416,659	4
2024-09-23	Eichenbaum, Kenneth D.	Director	-	Direct	Purchase	4,000	5.89	$23,560.00	4,000	4
2024-05-23	Boyd, Ralph F Jr	Director	-	Direct	Purchase	4,000	7.13	$28,520.00	6,000	4
2024-05-22	Huss, Beverly A	Director	-	Direct	Purchase	4,300	6.86	$29,498.00	4,300	4
2024-05-21	Chupa, Addam	Officer	Executive VP and CIO	Direct	Purchase	1,000	6.67	$6,670.00	24,774	4
2024-05-20	Steele, Barry G	Officer	Executive VP and CFO	Direct	Purchase	3,000	6.47	$19,410.00	70,195	4
2024-05-20	Gendron, Paul Andrew	Director	-	Direct	Purchase	5,000	6.54	$32,700.00	65,000	4
2024-05-20	Funke, Jerod	Officer	EVP-Chief HR Officer	Direct	Purchase	1,000	6.39	$6,390.00	1,000	4
2023-09-06	Malhotra, R. Rimmy	Director	-	Indirect	Sale	12,500	10.09	$126,125.00	45,000	4
2023-09-05	Malhotra, R. Rimmy	Director	-	Indirect	Sale	5,000	10.19	$50,950.00	57,500	4
2023-08-30	Malhotra, R. Rimmy	Director	-	Indirect	Sale	5,000	10.17	$50,850.00	85,000	4
2023-08-25	Malhotra, R. Rimmy	Director	-	Indirect	Sale	10,000	10.20	$102,000.00	105,000	4
2023-08-18	Malhotra, R. Rimmy	Director	-	Indirect	Sale	19,856	10.66	$211,664.96	125,000	4
2023-08-15	Malhotra, R. Rimmy	Director	-	Indirect	Sale	15,000	10.68	$160,200.00	170,416	4
2023-06-16	Lehman, Gregg Owen	Director	-	Direct	Sale	25,000	9.11	$227,750.00	346	4
2023-06-08	Malhotra, R. Rimmy	Director	-	Indirect	Sale	20,000	8.70	$174,000.00	190,416	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

65.76%

Inst. Shares: 13,290,995

Shares Outstanding: 20,211,045

2025-12-31

63.63%

Inst. Shares: 13,144,289

Shares Outstanding: 20,657,877

2025-09-30

61.11%

Inst. Shares: 12,475,235

Shares Outstanding: 20,413,636

2025-06-30

63.84%

Inst. Shares: 13,283,804

Shares Outstanding: 20,806,967

2025-03-31

61.11%

Inst. Shares: 12,909,630

Shares Outstanding: 21,125,019

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	13,290,995	20,211,045	65.76%
2025-12-31	13,144,289	20,657,877	63.63%
2025-09-30	12,475,235	20,413,636	61.11%
2025-06-30	13,283,804	20,806,967	63.84%
2025-03-31	12,909,630	21,125,019	61.11%
2024-12-31	14,017,910	21,271,608	65.90%
2024-09-30	13,734,027	21,290,512	64.51%
2024-06-30	13,600,765	21,299,089	63.86%
2024-03-31	13,422,923	21,225,768	63.24%
2023-12-31	12,444,163	21,024,382	59.19%
2023-09-30	12,503,484	21,095,404	59.27%
2023-06-30	12,045,824	20,955,048	57.48%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

InfuSystem Holdings, Inc (INFU) — SEC Financial Statements & Analysis

InfuSystem Holdings, Inc (INFU) is a surgical & medical instruments & apparatus company, incorporated in DE. InfuSystem Holdings, Inc trades on NYSE as: INFU. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), InfuSystem Holdings, Inc reported a 5.25% year-over-year revenue growth, a Gross Profit Margin of 56.69% (TTM), a Debt-to-Equity ratio of 0.65x, a Price-to-Sales (P/S) ratio of 1.34x (TTM), a Price-to-Book (P/B) ratio of 3.27x (TTM), at a market cap of $193.69M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 5.25%
Gross Profit Margin TTM: 56.69%
Debt To Equity: 0.65x
P/S TTM: 1.34x
P/B TTM: 3.27x
Market Cap: $193.69M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is InfuSystem Holdings, Inc in?

InfuSystem Holdings, Inc (INFU) operates in the Surgical & Medical Instruments & Apparatus industry.

What is INFU's market cap?

InfuSystem Holdings, Inc (INFU) has a market capitalization of $193.69M as of 2026-06-30.

What is INFU's P/E ratio?

InfuSystem Holdings, Inc (INFU)'s trailing twelve month P/E ratio is 26.68x as of 2026-06-30.

What exchange does INFU trade on?

InfuSystem Holdings, Inc (INFU) trades on the NYSE.

Where is InfuSystem Holdings, Inc incorporated?

InfuSystem Holdings, Inc is incorporated in DE.